JOUNCE THERAPEUTICS INC (JNCE)
Institutional ownership reported to the SEC as of Q2 2023, across 19 quarters.
1
Reporting holders
$917.8K
Reported value
0.0%
Held as options
-65
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Opaleye Management Inc. | $917.8K | 669,944 | 0.22% | 2q | -76.7%-$3.0M |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2023 | 1 | $917.8K | 669,944 | 0 | 0 | 1 | 0.0% |
| Q1 2023 | 66 | $54.7M | 29,471,106 | 19 | 18 | 13 | 0.2% |
| Q4 2022 | 61 | $33.3M | 29,984,675 | 6 | 15 | 22 | 0.0% |
| Q3 2022 | 101 | $100.1M | 42,544,952 | 18 | 28 | 33 | 0.6% |
| Q2 2022 | 100 | $129.4M | 42,680,700 | 13 | 34 | 28 | 0.1% |
| Q1 2022 | 112 | $287.9M | 42,286,641 | 9 | 29 | 41 | 0.3% |
| Q4 2021 | 125 | $349.6M | 41,828,577 | 19 | 33 | 32 | 0.2% |
| Q3 2021 | 115 | $271.4M | 36,414,263 | 11 | 40 | 36 | 0.3% |
| Q2 2021 | 129 | $247.3M | 36,031,604 | 23 | 61 | 23 | 0.8% |
| Q1 2021 | 119 | $382.1M | 36,833,515 | 37 | 31 | 32 | 1.0% |
| Q4 2020 | 103 | $197.3M | 27,766,262 | 15 | 25 | 40 | 1.6% |
| Q3 2020 | 101 | $210.7M | 25,404,404 | 20 | 20 | 39 | 1.5% |
| Q2 2020 | 92 | $181.0M | 26,130,764 | 13 | 28 | 32 | 0.4% |
| Q1 2020 | 88 | $126.4M | 26,479,650 | 14 | 35 | 21 | 0.5% |
| Q4 2019 | 98 | $225.2M | 25,645,263 | 33 | 30 | 24 | 0.8% |
| Q3 2019 | 78 | $80.8M | 24,233,310 | 10 | 27 | 22 | 0.1% |
| Q2 2019 | 80 | $122.2M | 24,603,117 | 7 | 28 | 31 | 0.5% |
| Q1 2019 | 81 | $156.8M | 25,264,597 | 9 | 25 | 29 | 0.1% |
| Q4 2018 | 84 | $82.3M | 24,424,493 | 4 | 2 | 1 | 0.0% |